oxazoles has been researched along with ramipril in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liebisch, B | 1 |
Baader, M; Breitschopf, K; Falk, E; Gerl, M; Kramer, W; Linz, W; Rütten, H; Schäfer, HL; Wohlfart, P | 1 |
Bakan, E; Borekci, B; Kumbasar, S; Kumtepe, Y; Salman, S; Suleyman, H; Yilmaz, M | 1 |
3 other study(ies) available for oxazoles and ramipril
Article | Year |
---|---|
[Case report: hypertension after stroke].
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Basal Ganglia Cerebrovascular Disease; Blood Pressure Monitoring, Ambulatory; Blood Urea Nitrogen; Body Weight; Cerebral Infarction; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Internal Capsule; Male; Oxazoles; Prognosis; Ramipril; Rilmenidine; Sympathetic Nervous System | 2004 |
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Biomarkers; Cardiotonic Agents; Cell Line; Disease Progression; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Male; Molecular Structure; Nitric Oxide Synthase Type III; Oxazoles; PPAR alpha; Ramipril; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Survival Rate; Thiazolidinediones | 2009 |
Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue.
Topics: Amlodipine; Animals; Antihypertensive Agents; Antioxidants; Clonidine; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Methyldopa; Ovary; Oxazoles; Oxidants; Ramipril; Rats; Rats, Wistar; Rilmenidine; Superoxide Dismutase | 2011 |